Apart from finding that the MDM2 SNP309 polymorphism increases the risk of lung cancer development with a statistical significance, particularly in never smoking and Asian populations, we explored the relationships between the MDM2 SNP309 polymorphism and the risk of lung cancer based on subgroups of different gender and histology using the most appropriate genetic model. Here, MDM2 is linked to lung carcinoma.